MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 201 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,117,880 | -91.9% | 89,934 | -90.8% | 0.00% | -93.2% |
| Q1 2023 | $13,746,010 | -22.2% | 981,157 | -20.6% | 0.06% | -37.9% |
| Q4 2022 | $17,674,066 | +1220.9% | 1,235,085 | +2257.0% | 0.10% | +1087.5% |
| Q3 2022 | $1,338,000 | +116.5% | 52,401 | +141.0% | 0.01% | +60.0% |
| Q2 2022 | $618,000 | -46.2% | 21,741 | -33.2% | 0.01% | -50.0% |
| Q1 2022 | $1,148,000 | -75.4% | 32,556 | -70.8% | 0.01% | -72.2% |
| Q4 2021 | $4,675,000 | +117.4% | 111,583 | +154.7% | 0.04% | +33.3% |
| Q3 2021 | $2,150,000 | +18.9% | 43,809 | +1.1% | 0.03% | +28.6% |
| Q2 2021 | $1,809,000 | +8.4% | 43,349 | -7.4% | 0.02% | -19.2% |
| Q1 2021 | $1,669,000 | +509.1% | 46,836 | +380.3% | 0.03% | +550.0% |
| Q4 2020 | $274,000 | – | 9,751 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |